(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)
Dec 30 (Reuters) - European stocks edged higher on Wednesday as Britain approved a COVID-19 vaccine developed by AstraZeneca and Oxford University, while bets of more U.S. fiscal aid and massive vaccination efforts spurred hopes of a strong global economic recovery next year.
The pan-European STOXX 600 .STOXX rose 0.1% by 0810 GMT, hovering near a 10-month high hit in the previous session.
Shares in AstraZeneca AZN.L were up 1.3% after jumping 3.3% earlier in anticipation of the news. The drugmaker said the authorisation was for a two-dose regime, and that the vaccine had been approved for use for emergency supply as Britain battles a new, highly contagious variant of the virus. markets in the region were subdued due to thin volumes in a holiday-shortened week. The German DAX .GDAXI was flat, while French .FCHI and Spanish stocks .IBEX slipped 0.1% each.
Unicaja UNI.MC rose more than 2% and Liberbank LBK.MC was down 3.6% after they announced an all-in share deal that would create Spain's fifth-biggest bank with around 110 billion euros ($134.71 billion) in assets.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.